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ABSTRACT
Whey protein isolate (WPI) solutions (100 g L-1 protein) were subjected to a
heat-treatment of 80 ºC for 10 min. Un-heated and heat-treated WPI solutions were
hydrolysed with Corolase® PP at pilot-scale to either 5 or 10 % degree of hydrolysis
(DH). Hydrolysates were subsequently processed via cascade membrane fractionation
using 0.14 μm, 30, 10, 5 and 1 kDa molecular weight cut-off membranes. The 
compositional and molecular mass distribution profiles of the substrate hydrolysates
and membrane processed fractions were determined. Whole and fractionated
hydrolysates were assayed for both angiotensin-I-converting enzyme (ACE)
inhibitory activity and ferrous chelating capabilities. A strong positive correlation (P
< 0.01) was established between the average molecular weight of the test samples and
the concentration needed to chelate 50 % of the iron (CC50) in solution. The lowest
ACE inhibition concentration (IC50 = 0.23 g L-1 protein) was determined for the 1 kDa
permeate of the heat-treated hydrolysate hydrolysed to 10 %DH.
KEYWORDS: hydrolysis; ACE; iron-binding; pilot-scale; bio-functional hydrolysates; heat-
treatment
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1. Introduction
The functional properties of proteins are related to their structural
characteristics. Processing steps, such as heat-treatment, can induce structural
alterations in whey proteins which may affect protein techno- and bio-functional
attributes. These alterations modify the physico-chemical characteristics (O’Loughlin,
Murray, Kelly, FitzGerald, & Brodkorb, 2012) and susceptibility to enzymatic
hydrolysis (Boye, Ma, & Harwalker, 1997). The enzymatic release of bio-functional
peptides from whey proteins has resulted in the generation of ingredients with
potential to, for example, control hypertension (Tavares, Contreras, Amorim, Pintado,
Recio, & Malcata, 2011) and enhance mineral binding (Kim, Seo, Khan, Ki, Nam, &
Kim, 2007b).
Hypertension induces blood vessel constriction and a reduction in elasticity as
well as hypertrophy and collagen deposition within the vascular system resulting in
increased risk of cardiovascular diseases (Dézsi, 2000). Upon renin cleavage of
angiotensinogen to release angiotensin I, the glycoprotein angiotensin-I-converting
enzyme (ACE) converts angiotensin I to the potent vasoconstrictor angiotensin II.
Much research has been conducted into bio-functional ingredients which possess
ACE-inhibitory activity for incorporation into food products to aid, or reduce the
reliance on, antihypertensive drugs, such as Captopril®. Numerous reports of whey
protein derived inhibitory peptides exist in the literature (Morris & FitzGerald, 2008;
Mullally, Meisel, & FitzGerald, 1997; Norris & FitzGerald, 2013).
Iron deficiency affects an estimated 2 billion people worldwide (Zimmermann
& Hurrell, 2007). The inter-conversion of iron to its different oxidation states is
utilised by biological systems for electron transfer, ligand binding, cell growth and
differentiation. Iron needs to be in a soluble format in order to be effectively
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absorbed. Direct fortification of food products with iron is problematic due to its
reactivity and ability to generate reactive oxygen species (ROS) and low solubility
(Fidler et al., 2004). Thus, interest in mineral-binding hydrolysates has focused on
their ability to reduce the reactivity and enhance the solubility of iron in fortified
foods (Ait-Oukhatar et al., 2002).
For these reasons iron-binding hydrolysates and fractions derived from whey
protein substrates have garnered significant interest of late. Iron-binding peptide
complexes have been produced through hydrolysis, e.g., alcalase hydrolysis of β-
lactoglobulin (Zhou et al., 2012). From this study an optimum mass ratio for complex
formation at neutral pH was determined to be 40 (hydrolysate): 1 (iron, as FeCl3).
Peptic hydrolysis of lactoferrin can liberate ‘lactoferricin’, f(17-41), which has been
shown to exhibit iron-binding capacity (Vegarud, Langsrud, & Svenning, 2000;
Wakabayashi, Takase, & Tomita, 2003). Fractionated hydrolysates of heated (100 ºC,
10 min) WPC high in alanine, phenylalanine and lysine with improved iron-binding
capabilities have been reported (Kim et al., 2007a). Also, digestion of α-la-enriched 
formulas have exhibited increased absorption of iron using infant rhesus monkeys as a
animal model (Kelleher, Chatterton, Nielsen, & Lonnerdal, 2003). Hydrolysates may
be subsequently formulated into products demonstrating enhanced mineral absorption
characteristics, similar to, for example Capolac® (Arla Food Ingredients).
While recent investigations into dual functionalities and thermal pre-
treatments of whey proteins have been published (Adjonu, Doran, Torley, & Agboola,
2013), there remains little literature available on the kinetics of pilot / semi-pilot scale
WPI hydrolysis and the compositional and bioactive properties of, and consequences
for, resulting hydrolysates. The primary objectives of this study were two-fold.
Firstly, the scale-up of a high viscosity, aggregated WPI dispersion with limited
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solubility from a previous thermally-denatured WPI laboratory hydrolysis process
(O’Loughlin et al., 2012). Secondly, investigation of the bio-functional, namely; anti-
hypertensive and ferrous chelation, attributes of these hydrolysates and membrane
processed fractions of heat-treated and un-heated control WPI dispersions.
Concomitant relationships between selective process treatments and bio-
functionalities were also investigated.
2. Materials and methods
2.1 Materials
Whey Protein Isolate (Isolac®) was provided by Carbery Food Ingredients,
(Ballineen, Co. Cork, Ireland). The powder contained 89.3 % (w/w) protein by
Kjeldahl [N x 6.38, (Merrill & Watt, 1973)]. The level of denaturation of the starting
material was 6.8 % w/w determined via isoelectric precipitation at pH 4.6 (Parris &
Baginski, 1991). The digestive-enzyme complex Corolase® PP was from AB
Enzymes GmbH (Darmstadt, Germany) and is compositionally described elsewhere
(Mullally, O'Callaghan, FitzGerald, Donnelly, & Dalton, 1994). Corolase® PP
possesses GRAS status and high proteolytic activity in whey producing non-bitter
hydrolysates (Svenning, Brynhildsvold, Molland, Langsrud, & Vegarud, 2000).
All other reagents and chemicals were procured from Sigma-Aldrich (Dublin,
Ireland) unless otherwise stated. All experiments were determined in duplicate unless
otherwise stated.
2.2 Pilot-scale heat treatment and enzymatic hydrolysis of WPI
WPI was reconstituted to 107 g L-1 on a protein basis with reverse-osmosis
water (RO) in a jacketed 316-grade stainless steel vessel fitted with a gated scrape
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surface agitator. The WPI dispersions (at pH 6.4) were adjusted to pH 8.0 with 4 N
NaOH and then diluted to 100 g L-1 protein with RO water to a final volume of 400 L.
Heat-treated WPI dispersions were brought to 80 °C for 10 min by indirect steam
injection before cooling to 50 ºC utilising chilled water.
Enzymatic hydrolysis at 50 ºC was initiated by the addition of Corolase® PP.
The pH was maintained at pH 8.0 throughout the reaction by manual titration with 4
N NaOH using a Sandpiper® air-operated double-diaphragm polypropylene pump
(Warren Rupp Inc., OH, USA) and a DEM JCS-60 floor scales (DEM Machines Ltd.,
Naas, Ireland) to monitor base addition. The degree of hydrolysis (DH) was
determined from the volume of base consumed (Adler-Nissen, 1986; O’Loughlin et
al., 2012). The enzyme:substrate ratio (E:S) employed varied depending on the target
DH. An E:S of 2:300 (0.67 %, w/w) on a protein equivalent basis was utilised to
generate hydrolysates at a DH of 5 %, whereas for 10 %DH hydrolysates an E:S of
1:100 (1.0 %, w/w) was employed. The reaction was terminated by heating the
hydrolysate solutions 85 ºC for 25 sec in a Unison H17 109 plate-and-frame 53 L
heat-exchanger plant (Unison Engineering Services Ltd., Limerick, Ireland). A 50 L
sample of the heat-inactivated hydrolysate was withdrawn, evaporated (to ~40 % total
solids) on a Tetra Scheffers™ falling-film single-stage evaporator (Tetra Pak,
Gorredijk, The Netherlands) and spray dried using a pilot scale Anhydro Lab 3 spray
drier (SPX Flow Technology A/S, Soeborg, Denmark). Inlet and outlet temperatures
during spray drying ranged from 185 – 190 and 85 – 90 °C, repectively.
2.3 Microfiltration and ultrafiltration of WPI hydrolysates
The remaining hydrolysate sample (~350 L) was subjected to cascade
membrane fractionation utilising a GEA Model F unit (GEA Process Engineering
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A/S, Skanderborg, Denmark). For hydrolysates at 5 % and 10 % DH which were
derived from heat-treated WPI, intial fractionation was via microfiltration (MF). MF
was accomplished with three Tami Isoflux™ ceramic membranes (25 x 1178 mm, 23
channels, Tami Industries, Nyons Cedex, France) having a nominal molecular weight
cut off (MWCO) of 0.14 µm and a total membrane area of 1.05 m2. MF was carried
out at 50 ºC to a volume concentration factor (VCF) of 8. A feed recirculation rate of
1500 L h-1 at 1 bar and membrane inlet pressure of 4.2 bar were maintained
throughout processing. For hydrolysates to 5 %DH of un-heated control substrates
two 30 kDa MWCO Koch KMS HFK™-328 spiral wound membranes (96 x 965 mm,
Koch Membrane Systems, Wilmington, MA, US) were used as the initial
fractionation step. For control hydrolysates to the 10 % DH level two 10 kDa MWCO
Koch spiral wound membranes were utilised.
In all cases, the subsequent permeate stream (~ 300 L) prepared above was
then subjected to ultrafiltration (UF) using the same GEA model F unit fitted with two
Koch KMS HFK™-328 spiral wound membranes. These membranes have a nominal
MWCO of 5 kDa and a total surface area (TMA) of 11.2 m2. The 5 kDa permeate
stream (~300 L) was then processed (at 50 ºC) on the GEA model F plant fitted with
two 1 kDa MWCO Alpha Laval UF-ETNA spiral wound membranes (TMA 11.2 m2,
95 x 965 mm, Alpha Laval AB, Lund, Sweden) to a VCF of 3, whereupon feed
volume was returned to 300 L with RO and UF was carried out to a final VCF of 7. A
feed recirculation rate of 1500 L h-1 at 1 bar and membrane inlet pressure of 5 bar
were maintained throughout processing. All process streams, with the exception of 1
kDa retentates and permeates, were dehydrated in a pilot scale Anhydro Lab 3 spray
drier using the conditions as described above. The 1 kDa retentates and permeates
were further concentrated (to ~35 % total solids) before spray drying, as outlined
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above, in a Anhydro F1 Lab single effect falling film evaporator. As an example, the
process flow diagram for the production of fractionated powders from hydrolysed (to
10 % DH) heat-treated WPI is shown in Appendix A (Fig. A. 1). Final volumes prior
to concentration and total solids levels are provided in Appendix B for all four
processes (Fig. B. 1).
2.4 Particle size, chromatography and compositional analysis of control and heated-
treated WPI and hydrolysates
Particle size analysis was carried out using a Malvern Mastersizer MSS
(Malvern Instruments Ltd., Worcestershire, U.K.) according to the protocol of
O’Loughlin et al. (2012). Size-exclusion chromatography (SEC) on samples was
carried out according to the protocol of O’Loughlin et al. (2013b).
Protein content was determined by micro-Kjeldahl on a Foss KjeltecTM 8400
(Foss, Hillerød, Denmark). The procedure was modified from Koops et al. 1975
(Koops, Klomp, & Elgersma, 1975) where a conversion factor of 6.38 was used in
accordance with Merrill, 1973 (Merrill et al., 1973). Ash was determined
gravimetrically through modification of the International Dairy Federation (IDF)
method (International Dairy Federation, 2008) where ≥ 1 g of powder was weighed to 
the nearest 0.1 mg. Moisture content was determined through heating at 102 °C ± 2
°C for 2 hrs according to the respective IDF method (International Dairy Federation,
2004). Lactose was determined using a food analysis lactose/galactose test kit (Roche
Diagnostics GmbH, Mannheim, Germany). Determination of free-amine (NH2)
groups was determined via the 2,4,6-trinitrobenzene 1-sulfonic acid (TNBS)
methodology of Adler-Nissen (1979) modified by O’Loughlin et al. (2012).
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2.5 Angiotensin-I-coverting enzyme inhibition assay
ACE was extracted from rabbit lung acetone powder reconstituted in 100 mM
sodium borate buffer according to the method of Cushman & Cheung (1971).
Subsequently, the inhibition of ACE activity was measured by HPLC through
modification of the method of Jiang et al. (Jiang, Tian, Brodkorb, & Huo, 2010).
Hippuryl-histine-leucine (Hipp-his-leu), 1mM, was dissolved in 50 mM sodium
borate buffer (pH 8.3) containing 0.5 M NaCl. A mixture containing 120 μL Hipp-his-
leu solution and 20 μL sample (10 g L
-1) was pre-incubated at 37 ºC for 5 min
whereupon 10 μL of ACE solution (~ 133 nano-katal at 37 ºC) was added and the 
mixture incubated for 60 min. The reaction was stopped by the addition of 150 μL of 
1 M HCl. Hippuric acid liberated by ACE was determined by RP-HPLC where
samples were eluted under gradient elution using a Symmetry C18 (2.1 mm x 150
mm, 5 μm) from Waters (Milford, MA, USA) at 28 ºC. Samples were filtered through 
0.45 μm filters (Sartorius Stedim Biotech GmbH, Germany) and 5 μL was injected 
onto the column. The gradient elution conditions were as follows; 0 to 100 % solvent
B for 20 min, 100 % solvent B for 5 min, 100 to 0 % solvent B for 5 min and 0 %
solvent B for 5 min at a flowrate of 0.2 mL min-1. Solvent A was Milli-Q water, 0.1 %
TFA (v/v) and solvent B was 100 % MeCN, 0.1 % TFA (v/v). The absorbance of the
eluent was measured at 228 nm. A response curve for hippuric acid ranging from 0.5
– 5 mM gave the following equation of the line;
y = 4.0 x 106x + 461732 (R2 = 0.995) (Eqn. 1)
The percentage ACE inhibitory activity was calculated according to the following
formula;
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ACE inhibitory activity (%) = [(A0 – A1) / A0]∙100         (Eqn. 2) 
Where: A0 was the absorbance at 228 nm of hippuric acid without addition of sample
and A1 was the absorbance of hippuric acid after incubation with sample.
The concentration of selected hydrolysates needed to inhibit the ACE by 50 % (IC50)
was determined by assaying % ACE inhibition at different concentrations of
hydrolysates. Experiments were conducted in triplicate. Captopril® (2S-1-[2S-2-
methyl-3-sulfanylpropanoyl] pyrrolidine-2-carboxylic acid) was used as a standard
where an IC50 of 15.4 nM was obtained under assaying conditions.
2.6 Total iron concentration and ferrous chelating activity determination
The concentration of total iron present in the WPI, the hydrolysates and their
respective fractions was determined using a modification of the method of Viollier et
al. (Viollier, Inglett, Hunter, Roychoudhury, & Van Cappellen, 2000). A standard
curve was prepared with 0 – 1,500 μg Fe
2+ L-1 from a standard solution of 1.79 M
FeSO4.7H2O in 0.5 M HCl. Test samples (1 g L-1 protein) were dissolved in 0.5 M
HCl and stored overnight. Test samples (200 μL) were added to 1,500 μL of distilled 
water to which 300 μL of 1.4 M hydroxylamine hydrochloride in 2 M HCl was added. 
The mixture was vortexed on a IKA® MS2 Minishaker (IKA® GmbH & Co. KG,
Staufen, Germany) at 1,000 min-1 and allowed to stand at room temperature for 30
min. Following this, 200 μL of ferrozine reagent (0.01 M in 0.1 M CH3COONH4) and
300 μL of 5 M CH3COONH4 was added and the mixture was allowed to stand for 3
min. The absorbance was read at 562 nm on a Varian Cary® 1 dual beam UV-visible
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spectrophotometer (Varian Ltd., Walton-on-Thames, UK). A reaction mixture where
the test sample volume was replaced with dH2O was used as a blank. A response
curve for 0 – 1.5 x 10-3 g L-1 iron (as FeSO4.7H2O) gave a linear response within this
range and the following equation of the line;
y = 0.0004x + 0.0259 (R2 = 0.999) (Eqn. 3)
Total iron was then determined according to the following formula;
Total iron (μg L
-1) = [(A562 – 0.0259) / 0.0004] (Eqn. 4)
The ferrous chelating activity was determined using a modification of the
method of Decker & Welch (1990). Test samples (1 mL of 1 g L-1) were mixed with
1,350 μL of dH2O and 50 μL of 2 mM FeCl2 and the mixture vortexed at 1,000 min-1
for 1 min. The reaction was initiated by the addition of 100 μL of 5 mM ferrozine and 
the samples vortexed again and allowed to stand at room temperature for 10 min. The
absorbance was read at 562 nm as described previously. EDTA-Na2 was used as a
positive control for chelation. The ferrous chelating activity was then determined
according to the following formula;
Ferrous chelating activity (%) = [(A0 – (A1 – A2)]/A0∙100        (Eqn. 5) 
Where: A0 was the absorbance of the control at 562 nm, A1 was the absorbance of the
sample at 562 nm and A2 was the absorbance of the blank at 562 nm.
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The concentration of selected hydrolysates needed to chelate 50 % of the ferrous iron
(CC50) from 2 mM FeCl2 was determined through assaying 0.5 – 10 g L-1 test
samples. These chelation experiments were determined in triplicate.
2.7 Statistical analysis
Statistical analysis was performed using Minitab 15 software (Minitab Inc.,
State College, PA, USA). Data is presented as mean ± SD. Statistical difference of
means was determined by one-way ANOVA followed by a Tukey test. For correlation
analysis the critical Pearson’s r coefficient for P < 0.01 was determined to be 0.549.
3. Results and discussion
Background studies by the authors and others have highlighted the
significance of using thermally-denatured WPI as a substrate in terms of structural
and molecular implications. O’Loughlin et al. (2012) demonstrated the changes
arising during Corolase® PP catalysed hydrolysis reaction as a result of heat-induced
protein aggregation due to pre-hydrolysis heat-treatments and the consequences of
this from a molecular perspective were subsequently studied (O'Loughlin, Murray,
Brodkorb, FitzGerald, & Kelly, 2013a; O’Loughlin et al., 2013b).
3.1 Characterisation of heat-treatment, hydrolysis and fractionation of WPI
solutions
Heat-treatment (80 ºC, 10 min) of WPI resulted in aggregate formation and a
reduction in determined ‘native-like’ protein (Tolkach, Steinle, & Kulozik, 2005) of
~64 % (results not shown). Using laser light scattering, the particle size was seen to
increase from 16.1 ± 0.5 μm (D.v 09) in the control WPI to 58.3 ± 1.1 μm in the heat-
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treated dispersion – slightly higher than that previously generated (mean particle size
40.2 ± 0.6 μm) during laboratory scale heat-treatment of WPI (O’Loughlin et al., 
2012). The development of smaller particle sizes at laboratory scale was attributed to
more efficient agitation using a three-bladed impeller. Pre-heat treatment of WPI
dispersions resulted in 29 and 34 % reductions in the time required to reach 5 and 10
% DH, by comparison with the respective hydrolysates from the un-heated control
WPI (Fig. 1). These results are in general agreement with those obtained previously at
the laboratory scale (O’Loughlin et al., 2012). However, the extent of decrease in
reaction time was lower for the pre-heat treated WPI hydrolysates generated at pilot-
scale. This may be related to the scale of the experiment (400 L) and the need to
employ a lower E:S in order to control the reaction and facilitate efficient heat-
inactivation of this larger volume. Also, at pilot scale the particle size difference may
be due to altered substrate accessibility.
Heat-treatment of WPI induced a shift in the molecular weight (Mw)
distribution of the starting material (Tables 1 and 2). Hydrolysis to 5 %DH of the
heat-treated WPI (Table 1) resulted in a higher percentage soluble material < 1 kDa
(~34 %) compared to the equivalent control hydrolysate (~27 %). Hydrolysis of the
heat-treated WPI resulted in an increase in the percentage soluble material to ~57 %
(results not shown). There was a significant (P < 0.05) increase in the ash content in
the 5 % DH hydrolysate of the heat-treated WPI (~9 %) compared to the control
hydrolysate (~7 %). It was not possible to utilize a 30 kDa molecular weight cut-off
(MWCO) membrane in the fractionation of the 5 % and 10 %DH hydrolysates of
heat-treated (80 ºC for 10 min) WPI due to the high level of insoluble aggregated
material (39 ± 2.1 % (w/w), results not shown). Therefore, a 0.14 μm CO MF step 
was first performed on the hydrolysates obtained from heat-treated WPI resulting in
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retentate powders which had a relatively low protein concentration, a high percentage
of soluble material > 30 kDa and a high ash content (Table 1). Interestingly, the
percentage soluble material 10 – 5 kDa increased in the unhydrolysed substrate, from
3.8 ± 0.9 to 26.1 ± 0.9 %, upon heat-treatment. This was due to the increased
insolubility and presence of large aggregates upon heating which resulted in only the
soluble fraction being available for distribution analysis.
As expected the higher level of hydrolysis at 10 % DH of unheated control
WPI favored an increased percentage soluble material < 1 kDa (Tables 1 and 2). Due
to the higher DH, a 10 kDa MWCO membrane was utilized to optimize the
fractionation process and the 10 kDa retentate of 10 % DH hydrolysate had ~50 %
soluble material > 30 kDa (Table 2). Also, hydrolysis of heat-treated WPI to 10 % DH
resulted in an increase in the percentage soluble material to 86 % (results not shown).
The most noteworthy difference between the 10 % DH hydrolysates of the control and
heat-treated WPI was the increase, by a factor of ~1.12, in soluble material < 1 kDa in
the heat-treated 1 kDa permeate compared to the corresponding control permeate.
Hydrolysis of the heat-treated WPI resulted in an increase in the percentage soluble
material to ~57 % (results not shown). These results are in agreement with a previous
study on the molecular mass distribution of aggregated dispersions which were
hydrolysed using a similar laboratory scale process (O’Loughlin et al., 2013b).
3.2 ACE inhibitory activity of WPI, pilot-scale hydrolysates and associated
membrane processed fractions
Samples (10 g L-1) of control and heat-treated WPI, their respective 5 and 10
% DH hydrolysates and the associated membrane processed fractions were analysed
for ACE inhibitory activity. The chromatographically determined changes in hippuric
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acid formation (Fig. 2) in the presence of the 5 kDa retenate of the control 10 % DH
hydrolysate are illustrated. Figure 2 also includes the inhibition profile for Captopril®
(inset Fig. 2). Heat-treatment of WPI increased ACE inhibitory activity by, on
average, a factor of 2.8 compared to the unheated control. The higher levels of
hydrolysis (10 % DH) resulting in a greater increase in ACE inhibitory activity (~ 73
% at 10 g L-1, Table 3) concurs with previous findings (Otte, Shalaby, Zakora, Pripp,
& El-Shabrawy, 2007).
Higher IC50 values, and lower potency ACE inhibition was observed following
concentration of higher Mw peptide material in the 30/10 kDa and 0.14 μm retentates 
compared to the un-fractionated whole hydrolysates. Correspondingly, the lowest IC50
value (0.23 ± 0.07 g protein L-1) was observed for the 1 kDa permeate of heat-treated
WPI hydrolysed to 10 % DH (Table 3). However, while generally the lower Mw
fractions possessed the highest ACE inhibitory activity, the correlation between
average Mw and inhibition activity was poor (r = 0.524, P < 0.01, results not shown).
This was exemplified in the case of the 5 kDa retentate fractions from the control and
heat-treated hydrolysates, which, while possessing similar Mw distributions (Table 1),
presented significant (P < 0.05) differences in ACE inhibitory activity (Table 3).
From Table 3, the 5 kDa retentate fraction from the hydrolysate of heat-treated WPI
possessed an IC50 of 2.63 g protein L-1 – a reduction by a factor greater than 7 in the
IC50 compared to respective fraction of the control hydrolysate (IC50 = 18.91 g protein
L-1). Also, this 5 kDa retentate fraction of the control 5 % DH hydrolysate represented
the highest ACE IC50 (least potent) value observed from the tested spray-dried
powders (Table 3). Mullally et al. (1997) demonstrated increased ACE inhibition in
the 3 kDa permeates of WPC / β-lg tryptic hydrolysates compared to the whole un-
fractionated hydrolysates (Mullally et al., 1997). However, from that study, the 1 kDa
Revised and submitted Word version of O’Loughlin et al. (2014). Int. Dairy J., 34, 146-152. doi: 10.1016/j.idairyj.2013.07.009
Page - 17 - of 31
permeates possessed lower ACE inhibitory activities than the 3 kDa permeates of the
respective hydrolysates. The cumulative beneficial effect of both prior heat-treatment
and higher DH is highlighted by the 10 % DH hydrolysate of the heat-treated WPI
which had the highest ACE inhibition of the un-fractionated hydrolysates assayed
(76.2 ± 1.2 %, Table 3).
3.3 Total iron and ferrous chelating capability of WPI, hydrolysates and fractions
Total iron content of the control WPI starting material (~ 228 μg L
-1) was in
accordance with published values (Hunt & Meacham, 2001). Partitioning during
hydrolysis treatments and fractionation resulted in values ranging from 38 ± 8 μg L
-1
for the 1 kDa permeate (at 1 g L-1) of the unheated control (10 % DH) to 419 ± 5  μg 
L-1 for the 30 kDa retentate of the unheated control (5 % DH) (results not shown).
The ferrous chelating capability, determined at 1 g L-1, exhibited significant
differences (P < 0.05) between the samples (Tables 3) with hydrolysis resulting in an
increase in the chelating capability of WPI by a factor of ≥ 2. Generally, greater iron 
chelation (~ 55.7 %) was measured in the lower Mw fractionated samples. The ferrous
chelating capability was higher for the 10 % DH hydrolysates compared to equivalent
5 % DH samples, irrespective of prior heat-treatment (Table 3). Interestingly, the
whole hydrolysates of the heat-treated WPI samples had a lower percentage chelating
ability (at 1 g L-1) than equivalent unheated control hydrolysates at both 5 and 10 %
DH. Overall, the highest percentage iron chelating ability (~ 55.7 %) was observed in
the 1 kDa permeate of the 10 % DH heat-treated WPI (Table 3).
The concentration of sample required for the chelation of 50 % of ferrous iron
under the assay conditions (CC50) followed a similar trend as those seen in the %
chelating ability. The lowest CC50 values were observed for the 1 kDa retentates and
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permeates of both the control and heat-treated WPI hydrolysates (Table 3). Generally,
lower CC50 values were seen with the 10 % DH samples and there appeared to be no
discernable effect of prior heat-treatment of the substrate on iron chelation. While the
1 kDa permeates of the 5 % DH hydrolysates subjected to heat-treatment possessed
lower iron CC50 values, in the 10 % DH samples the difference was not statistically
significant (P < 0.05). Overall, the highest iron CC50 value was in the 30 kDa retentate
of the unheated control 5 % DH hydrolysate (4.50 g L-1), with the lowest value in the
1 kDa permeate of the heat-treated 10 % DH hydrolysate (0.83 g L-1, Table 3).
There was a strong positive correlation (r = 0.918, P < 0.01) between the
average Mw and the concentration needed to chelate 50 % of the iron (CC50) in
solution (Fig. 3) – average Mw being determined through integration of SEC size
distribution data based on the area under the curve. For example, samples possessing
an average Mw of ≤ 20 kDa possessed an equivalent CC50 value of ≤ 2.68 g L-1 while
samples possessing an average Mw of < 1 kDa had CC50 values ≤ 0.86 g L-1.
Etcheverry et al. (2004) demonstrated higher iron chelating abilities with a 10 kDa
permeate of whey compared to non-fractionated whey indicative of the presence of
one or more low molecular mass Fe-binding components (Etcheverry, Miller, &
Glahn, 2004). Another previous study demonstrated improved iron absorption in
cellular models using hydrolysates of WPC with Mw ≤ 10 kDa (Ou et al., 2010).  
4. Conclusions
This pilot-scale study validates the findings of earlier laboratory experiments
demonstrating altered kinetic, molecular and physico-chemical characteristics of
hydrolysates obtained following pre-hydrolysis heat-treatments on WPI. Of particular
significance was the enhancement of ACE inhibitory activity present in WPI
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hydrolysates. This study demonstrated an increased ACE inhibitory activity as a direct
result of prior heat-treatment of the WPI substrate and enrichment of ACE inhibitory
activity in the lower Mw fractions. The ferrous chelating capability of the hydrolysate
fractions was directly correlated with the average Mw of the peptides within the
samples. There is a possibility that the bio-functionalities of these samples reflect the
cumulative effect of more than one peptide in the fraction. Future work is required in
the isolation and characterisation the active ingredients within these hydrolysates and
fractions. Nevertheless, this work demonstrates the process scale up of thermally-
denatured whey protein hydrolysis highlighting the concomitant consequences for
downstream bio-functionality.
5. Appendices
5.1 Appendix A
The process flow diagram for the heat-treatment, enzymatic hydrolysis and
subsequent membrane cascade fractionation of heat-treated (80 ºC for 10 min) WPI
hydrolysed to 10 % DH is shown in Fig. A. 1.
5.2 Appendix B
Total solids and final volume determinations for all four processes are
exhibited in Fig. B. 1.
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Figure 1. Hydrolysis profiles for whey protein isolate (WPI) unheated control and
heat-treated (HT) dispersions (100 g L-1) hydrolysed at pH 8 and 50 ºC to degree of
hydrolysis (DH) values of 5 or 10 % with Corolase® PP obtained using the pH-stat
methodology at pilot-scale (sample mean ± SD, n = 2).
Figure 2. Reversed-phase HPLC chromatogram showing the decrease in the formation
of hippuric acid (from a single run quantified at 228nm) as a result of increased
angiotensin-I-converting enzyme (ACE) inhibition for 5 kDa rentenate of the control
10 % DH hydrolysate. (Inset) ACE inhibition index determined with 6 – 24 nM of
Captopril® where 15.4 nM Captopril® led to 50 % inhibition (IC50) of ACE activity.
Figure 3. Correlation curve of the average molecular weight (Mw) of whey protein
isolate, hydrolysates and fractions and their respective concentrations required to
chelate 50 % of the ferrous iron from FeCl2 (CC50). Pearson’s r value was determined
to be 0.918 at P < 0.01.
Figure A. 1. Process flow diagram of heat-treated (80 ºC for 10 min) whey protein
isolate (WPI) hydrolysed to a degree of hydrolysis (DH) of 10 % and subsequently
micro- and ultra-filtered via membrane cascade fractionation. Where * = total solids,
** = solubility and *** = nominal molecular weight cut-off.
Figure B. 1. Total solids and final volume determinations for heat-treated (80 ºC for
10 min) and un-heated control whey protein isolate (WPI) hydrolysis processes
where; A: control WPI 5 % degree of hydrolysis (DH), B: heat-treated WPI 5 % DH,
C: control WPI 10 % DH and D: heat-treated WPI 10 % DH.
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Figure 3.
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Figure A. 1.
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Figure B. 1.
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